Gilead Sciences (GILD) Short-term Investments (2009 - 2026)

Gilead Sciences has reported Short-term Investments for 17 years, with the latest figure at $15.0 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments changed N/A year-over-year to $15.0 million; the trailing twelve-month figure through Mar 2026 stood at $15.0 million (changed N/A YoY), and the FY2025 full-year result was $68.0 million, changed N/A from the prior year.
• Short-term Investments for Q1 2026 stood at $15.0 million, down from $68.0 million in the prior quarter.
• The five-year high for Short-term Investments was $1.2 billion in Q4 2023, with the low at $15.0 million in Q1 2026.
• Historically, Short-term Investments has averaged $691.2 million across 4 years, with a median of $948.5 million in 2022.
• Annual changes were most pronounced in 2022 — Short-term Investments plunged 43.38% — and 2023, when it gained 21.17%.
• Gilead Sciences' Short-term Investments stood at $973.0 million in 2022, then gained by 21.17% to $1.2 billion in 2023, then slumped by 94.23% to $68.0 million in 2025, then slumped by 77.94% to $15.0 million in 2026.
• The last three Short-term Investments figures came in at $15.0 million (Q1 2026), $68.0 million (Q4 2025), and $19.0 million (Q3 2025), per Business Quant data.